News
Bevacizumab no better than placebo for epistaxis in HHT
of nasal spray Bevacizumab nasal spray is no more effective than a placebo for reducing epistaxis caused by hereditary hemorrhagic telangiectasia...
News
Improvements needed in SCD care, report says
Photo courtesy of St.
News
HSCT may age T cells as much as 30 years
Photo by Chad McNeeley New research suggests hematopoietic stem cell transplant (HSCT) may increase the molecular age of peripheral blood T cells...
News
Study reveals higher risk of injuries pre- and post-cancer diagnosis
Photo courtesy of the CDC Cancer patients have a heightened risk of injuries 16 weeks before and after their diagnosis, according to a large...
News
Blood cells emerge through internal struggle, study suggests
Image by Volker Brinkmann Developing blood cells are caught in a tug of war between competing gene regulatory networks before finally deciding...
News
Longer DAPT better for PAD, study suggests
Photo by Sage Ross ROME—A subanalysis of the PRODIGY study suggests a longer duration of dual antiplatelet therapy (DAPT) improves outcomes after...
News
FDA expands approval of blinatumomab
and solution for infusion Photo courtesy of Amgen The US Food and Drug Administration (FDA) has granted accelerated approval for blinatumomab (...
News
Edoxaban appears comparable to standard therapy
ROME—The novel oral anticoagulant edoxaban is a feasible treatment option for patients with atrial fibrillation (AF) who need anticoagulation...
News
Drug granted orphan designation for GVHD
Photo by Linda Bartlett The European Commission has granted orphan drug designation to ALXN1007 for the treatment of graft-versus-host disease (...
News
Simple algorithm can rule out PE, team says
Image courtesy of Medical College of Georgia ROME—A new study suggests the YEARS algorithm may provide a simple method for ruling out pulmonary...
News
FDA approves new indication for ofatumumab in CLL
Photo courtesy of GSK The US Food and Drug Administration (FDA) has approved the use of ofatumumab (Arzerra®) in combination with fludarabine and...
News
Study may explain why blood type affects cholera severity
Photo by Daniel Gay Results of preclinical research may explain why people with blood type O often get more severely ill from cholera than people...
News
Antiplatelet drugs comparable in patients with AMI
Photo courtesy of AstraZeneca ROME—The antiplatelet drugs prasugrel and ticagrelor produce similar early results in patients with acute...
News
Antidote to factor Xa inhibitors exhibits efficacy in patients with major bleeding
ROME—Preliminary results from the ANNEXA-4 study suggest that andexanet alfa, an investigational antidote to factor Xa inhibitors, can be...
News
Antiplatelet monitoring doesn’t benefit high-risk patient group
Photo courtesy of NIH ROME—Results of the ANTARCTIC trial suggest that monitoring platelet function to individualize antiplatelet therapy does...